Concepedia

Cavan Kalonia

CK

Statistics

Publications

14

Citations

720

H-Index

13

Active since

2013

Affiliations

AstraZeneca (United States)(Current)

University of Kansas

University of Manchester

Rutherford Appleton Laboratory

Imperial College London

Cavan Kalonia is an author at AstraZeneca (United States) specializing in biochemistry, monoclonal antibodies, and antibody stability.

ORCID

Publications per year

2013–2024

14

Publications

14

Structural Characterization of IgG1 mAb Aggregates and Particles Generated Under Various Stress Conditions

Srivalli Telikepalli, Ozan S. Kumru, Cavan Kalonia et al. · Journal of Pharmaceutical Sciences · 2014 · 135 citations · Full text

, , +14

Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody

Nicholas R. Larson, Yangjie Wei, Indira Prajapati et al. · Journal of Pharmaceutical Sciences · 2019 · 97 citations · Full text

, , +8

Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb

Saba Ghazvini, Cavan Kalonia, David B. Volkin et al. · Journal of Pharmaceutical Sciences · 2016 · 89 citations

, , +12

Understanding the Stabilizing Effect of Histidine on mAb Aggregation: A Molecular Dynamics Study

Suman Saurabh, Cavan Kalonia, Zongyi Li et al. · Molecular Pharmaceutics · 2022 · 84 citations · Full text

, , +17

Protein Adsorption and Layer Formation at the Stainless Steel–Solution Interface Mediates Shear-Induced Particle Formation for an IgG1 Monoclonal Antibody

Cavan Kalonia, Frank Heinrich, Joseph E. Curtis et al. · Molecular Pharmaceutics · 2018 · 66 citations · Full text

, , +14

1–5 of 14